23.50
-0.22(-0.93%)
Currency In USD
| Previous Close | 23.72 |
| Open | 23.77 |
| Day High | 23.9 |
| Day Low | 23.44 |
| 52-Week High | 24.82 |
| 52-Week Low | 7.85 |
| Volume | 942,102 |
| Average Volume | 1.42M |
| Market Cap | 4.09B |
| PE | -106.82 |
| EPS | -0.22 |
| Moving Average 50 Days | 19 |
| Moving Average 200 Days | 14.47 |
| Change | -0.22 |
If you invested $1000 in BrightSpring Health Services, Inc. Common Stock (BTSG) since IPO date, it would be worth $2,136.36 as of February 05, 2025 at a share price of $23.5. Whereas If you bought $1000 worth of BrightSpring Health Services, Inc. Common Stock (BTSG) shares 6 months ago, it would be worth $2,103.85 as of February 05, 2025 at a share price of $23.5.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
BrightSpring Health Services, Inc. Enters into Definitive Agreement to Divest Community Living Business to Sevita; Reports Preliminary 2024 Financial Results and Provides 2025 Guidance Excluding Community Living
GlobeNewswire Inc.
Jan 20, 2025 11:30 PM GMT
Streamlined organization and Provider Services segment to optimize resource allocationProvider Services focus on Home Health/Hospice, Personal Care, Rehabilitation Services, and Care Management strategic prioritiesProceeds from the sale will be used
BrightSpring Health Services, Inc. Announced Refinancing of Term Loan B
GlobeNewswire Inc.
Dec 11, 2024 9:05 PM GMT
LOUISVILLE, Ky., Dec. 11, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, completed the successful
BrightSpring Health Services Announces Onco360® Has Been Selected as a Partner for Several New Drugs
GlobeNewswire Inc.
Nov 26, 2024 10:00 PM GMT
LOUISVILLE, Ky., Nov. 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) is proud of its specialty pharmacy partner, Onco360®, for being selected as the national pharmacy part